Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Equities
  • Guidance
  • Large Cap
  • M&A
  • Movers
  • News

Why Blue Owl Capital Shares Are Higher Premarket Wednesday

By Lekha Gupta
April 3, 6:43 AM
Blue Owl Capital to acquire Kuvare Insurance Services LP for $750 million. Funding will be through cash and Class A shares. Potential $250 million earnout. AUM expected to be $20 billion post-acquisition. Accretive in 2024.

GABF

Read More
2 minute read
  • Guidance
  • News

Adaptive Biotechnologies Provides Strategic Review Update And Announces Preliminary Q1 2024 Revenue Of $41M-$43M Vs $38.21M Est.

By Benzinga Newsdesk
April 2, 4:12 PM
Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today

ADPT

Read More
1 minute read
  • Buybacks
  • Dividends
  • Equities
  • Guidance
  • Large Cap
  • M&A
  • Movers
  • News

ChampionX, Schlumberger Shares Move In Opposite Directions After $8B Deal Announcement

By Lekha Gupta
April 2, 1:56 PM
The transaction is projected to close before 2024, subject to shareholder and regulatory approval.

CHX

Read More
2 minute read
  • Equities
  • General
  • Guidance
  • Markets
  • Movers
  • News

Why Veeva Systems Shares Are Diving Tuesday

By Nabaparna Bhattacharya
April 2, 1:23 PM
Veeva Systems shares plummet as CFO Brent Bowman's tenure abruptly ends, alongside executive reshuffling and guidance reaffirmation.

VEEV

Read More
2 minute read
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Movers
  • News

Behind The Numbers: Paychex Delivers 4% Sales Growth In Q3, Raises Eyebrows With Revised Outlook

By Lekha Gupta
April 2, 11:15 AM
Paychex reported mixed Q3 results, with 4% sales growth and $1.38 EPS beating estimates. FY24 outlook revised to 5-6% revenue growth.

DIVS

Read More
1 minute read
  • Guidance
  • News

Veeva Reiterates Quarterly And Annual Guidance, Sees Q1 Revenue $640M-$643M Vs $641.94M Est.; FY25 Revenue $2.725B-$2.740B Vs $2.73B Est.

By Benzinga Newsdesk
April 2, 9:31 AM
Veeva Reiterates Quarterly and Annual Guidance Veeva is reiterating the following financial guidance issued on the Company's earnings call on February 29, 2024: For the quarter ending April 30,

VEEV

Read More
1 minute read
  • Guidance
  • News

PVH Corp. Sees FY24 EPS $10.75-$11.00 Vs $10.48 Est.; Revenue Is Projected To Decrease 6% To 7% As Compared To 2023

By Benzinga Newsdesk
April 1, 4:19 PM
2024 Outlook:Full Year 2024 GuidanceRevenue is projected to decrease 6% to 7% as compared to 2023 (decrease 6% to 7% on a constant currency basis), inclusive of a 2% reduction related to the sale of the Heritage Brands

PVH

Read More
1 minute read
  • Guidance
  • News

PVH Corp. Sees Q1 EPS $2.15 Vs $2.59 Est.; Revenue Is Projected To Decrease ~11% As Compared To The First Quarter Of 2023

By Benzinga Newsdesk
April 1, 4:18 PM
First Quarter 2024 GuidanceRevenue is projected to decrease approximately 11% as compared to the first quarter of 2023 (decrease approximately 10% on a constant currency basis), inclusive of a reduction of 3% related to

PVH

Read More
1 minute read
  • Earnings
  • Equities
  • Guidance
  • Movers
  • News

Why Is Vislink Stock Shooting Higher Today?

By Anusuya Lahiri
April 1, 10:30 AM
Vislink reported Q4 revenue of $8.1M, up from $7.4M with EPS loss of $(0.99) compared to consensus of $0.00. Gross margin rose to 46%.

VTI

Read More
1 minute read
  • Earnings
  • Guidance
  • News

Wetouch Technology Inc. Preannounces Revenue Of $39.71M For 2023 Vs $37.92M YoY

By Benzinga Newsdesk
April 1, 10:27 AM
Wetouch Technology Inc. (NASDAQ:WETH), a leading innovator in the global touch display industry, proudly announces its robust financial performance for the fiscal year 2023, showcasing remarkable growth and strong

WETH

Posts pagination

Previous 1 … 84 85 86 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service